What Pliant Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 4 |
| Total trades | 0 | 4 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 127,828 |
| Net activity | +0 | −127,828 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Kuo Minnie | Chief Operating Officer | Jan 20 | Sale for tax withholding · S | −6,917 | $1.28 | −$8.85K | 37,806 |
| Coulie Bernard | President and CEO | Jan 20 | Sale for tax withholding · S | −89,375 | $1.28 | −$114K | 505,601 |
| Cummings Keith Lamont | Chief Financial Officer | Jan 20 | Sale for tax withholding · S | −24,002 | $1.28 | −$30.7K | 297,214 |
| Cheung Lily | Chief Human Resource Officer | Jan 20 | Sale for tax withholding · S | −7,534 | $1.28 | −$9.64K | 44,847 |
| Coulie Bernard | President and CEO | Jan 23 | Grant / award · A | +162,500 | — | — | 593,017 |
| Cummings Keith Lamont | Chief Financial Officer | Jan 23 | Grant / award · A | +56,650 | — | — | 319,258 |
| Cheung Lily | Chief Human Resource Officer | Jan 23 | Grant / award · A | +25,875 | — | — | 50,425 |
| Ouimette Mike | General Counsel & Corp. Sec'y | Jan 23 | Grant / award · A | +35,000 | — | — | 105,544 |
| Hull Hans | Chief Business Officer | Jan 23 | Grant / award · A | +40,150 | — | — | 251,708 |
| Lefebvre Eric | Chief Medical Officer | Jan 23 | Grant / award · A | +45,650 | — | — | 240,224 |
| Ouimette Mike | General Counsel & Corp. Sec'y | Jan 22 | Disclosed 10b5-1 sale · S | −10,230 | $10.99 | −$112K | 70,544 |
| Cheung Lily | Chief Human Resource Officer | Jan 17 | Sale for tax withholding · S | −3,740 | $11.20 | −$41.9K | 24,550 |
| Cummings Keith Lamont | Chief Financial Officer | Jan 17 | Sale for tax withholding · S | −20,148 | $11.20 | −$226K | 262,608 |
| Coulie Bernard | President and CEO | Jan 17 | Sale for tax withholding · S | −52,419 | $11.20 | −$587K | 430,517 |
| Ouimette Mike | General Counsel & Corp. Sec'y | Jan 17 | Sale for tax withholding · S | −13,270 | $11.20 | −$149K | 80,774 |
| Hull Hans | Chief Business Officer | Jan 17 | Sale for tax withholding · S | −15,936 | $11.20 | −$179K | 211,558 |
| Lefebvre Eric | Chief Medical Officer | Jan 17 | Sale for tax withholding · S | −18,478 | $11.20 | −$207K | 194,574 |
| Coulie Bernard | President and CEO | Jul 10 | Sale for tax withholding · S | −38,710 | $11.56 | −$447K | 482,936 |
| Cummings Keith Lamont | Chief Financial Officer | Jul 10 | Sale for tax withholding · S | −10,911 | $11.56 | −$126K | 282,115 |
| Ouimette Mike | General Counsel & Corp. Sec'y | Jul 10 | Sale for tax withholding · S | −7,656 | $11.56 | −$88.5K | 94,044 |
Loading...